Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5865 Articles

Chris Lange | Nov 15, 2016 at 11:35 AM EST

BeyondSpring Gears Up for IPO

BeyondSpring has filed with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO).

Chris Lange | Nov 15, 2016 at 9:15 AM EST

Why Teva Sank Despite Solid Earnings and Guidance

Teva Pharmaceutical Industries released a mixed third-quarter earnings reports before the markets opened on Tuesday.

Chris Lange | Nov 14, 2016 at 12:25 PM EST

What to Look for in Teva Pharmaceuticals Earnings

Teva Pharmaceuticals has so far been unable to escape its rough patch in 2016. However there may now be a…

Chris Lange | Nov 14, 2016 at 10:50 AM EST

Why Dynavax Shares Are in Freefall

Dynavax Technologies Corp. (NASDAQ: DVAX) shares crumbled Monday morning after the company said that it received a Complete Response Letter…

Chris Lange | Nov 14, 2016 at 10:20 AM EST

Corbus Pharmaceuticals Skyrockets on Positive Mid-Stage Results

Corbus Pharmaceuticals shares skyrocketed on Monday morning after the company announced positive results from its mid-stage clinical trial in systemic…

Chris Lange | Nov 14, 2016 at 10:15 AM EST

Motif Bio Closes in on IPO

Motif Bio has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).

Lee Jackson | Nov 11, 2016 at 9:35 AM EST

Top Biotech and Health Care Stocks Set to Run on Huge Republican Sweep

With the Republicans now set to control both Congress and the White House, many on Wall Street feel that there…

Chris Lange | Nov 11, 2016 at 8:50 AM EST

Why PTC Therapeutics Is Soaring

PTC Therapeutics shares skyrocketed early on Friday after the company received positive news from the European Medicines Agency.

Jon C. Ogg | Nov 10, 2016 at 1:26 PM EST

Gilead Scores Another Hepatitis FDA Approval

Gilead Sciences has announced that the FDA has approved its once-a-day treatment for adults with chronic hepatitis B virus infection.

Chris Lange | Nov 10, 2016 at 11:55 AM EST

Anthera Pharmaceuticals Slides on Missed Late Stage Results

Shares of Anthera Pharmaceuticals lost roughly one-third of their value on Thursday after the company gave an update on its…

Chris Lange | Nov 10, 2016 at 7:40 AM EST

Short Interest Bets Increase on Major Pharma

Drug prices have been under pressure due to the campaign rhetoric, and short interest has increased in most of these…

Chris Lange | Nov 10, 2016 at 7:20 AM EST

Short Sellers Grow More Selective on Major Biotechs

Now that the U.S. presidential election is over and Hillary Clinton is out of the picture, major biotech companies can…

Chris Lange | Nov 9, 2016 at 4:42 PM EST

Mylan Rises on Mixed Earnings

Mylan N.V. (NASDAQ: MYL) released third-quarter earnings after markets closed on Wednesday. The company posted $1.38 in earnings per share…

Chris Lange | Nov 9, 2016 at 4:29 PM EST

Novavax Announces Restructuring Along With Mixed Q3 Earnings

Novavax, Inc. (NASDAQ: NVAX) reported third-quarter financial results after markets closed on Wednesday. The company said that it had a…

Jon C. Ogg | Nov 9, 2016 at 4:02 PM EST

5 Hospitals Slaughtered on the Clinton Loss (or Trump Win)

If there was one group of companies which actually got off close to Scott-free during the Obamacare experiment, it was…

1 … 184 185 186 187 188 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

BeyondSpring Gears Up for IPO

Why Teva Sank Despite Solid Earnings and Guidance

What to Look for in Teva Pharmaceuticals Earnings

Why Dynavax Shares Are in Freefall

Corbus Pharmaceuticals Skyrockets on Positive Mid-Stage Results

Motif Bio Closes in on IPO

Top Biotech and Health Care Stocks Set to Run on Huge Republican Sweep

Why PTC Therapeutics Is Soaring

Gilead Scores Another Hepatitis FDA Approval

Anthera Pharmaceuticals Slides on Missed Late Stage Results

Short Interest Bets Increase on Major Pharma

Short Sellers Grow More Selective on Major Biotechs

Mylan Rises on Mixed Earnings

Novavax Announces Restructuring Along With Mixed Q3 Earnings

5 Hospitals Slaughtered on the Clinton Loss (or Trump Win)

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that’s now reaching retirees’ statements

Which Big-Box Store Chain Has Dominated 2026: Walmart, Target, or Costco?

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that's now reaching retirees' statements

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that’s now reaching retirees’ statements

Live: Navitas Semiconductor Q1 Earnings Tonight. Can the 676% Surge Survive the Print?

Health and Healthcare Articles

All Health and Healthcare Articles

BeyondSpring Gears Up for IPO

Why Teva Sank Despite Solid Earnings and Guidance

What to Look for in Teva Pharmaceuticals Earnings

Why Dynavax Shares Are in Freefall

Corbus Pharmaceuticals Skyrockets on Positive Mid-Stage Results

Motif Bio Closes in on IPO

Top Biotech and Health Care Stocks Set to Run on Huge Republican Sweep

Why PTC Therapeutics Is Soaring

Gilead Scores Another Hepatitis FDA Approval

Anthera Pharmaceuticals Slides on Missed Late Stage Results

Short Interest Bets Increase on Major Pharma

Short Sellers Grow More Selective on Major Biotechs

Mylan Rises on Mixed Earnings

Novavax Announces Restructuring Along With Mixed Q3 Earnings

5 Hospitals Slaughtered on the Clinton Loss (or Trump Win)

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that’s now reaching retirees’ statements

Which Big-Box Store Chain Has Dominated 2026: Walmart, Target, or Costco?

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check

Featured Reads

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that's now reaching retirees' statements

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check